Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-Kell (K1) in ascitic fluid.

G H Longster, K E Major

    Vox Sanguinis
    |January 1, 1975
    PubMed
    Summary

    This study describes the persistent presence of anti-Kell (K1) antibodies in the ascitic fluid of an adenocarcinoma patient. These antibodies, along with anti-A and anti-B, were compared to those found in the patient's serum.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new method to study the efficiency of third generation blood filters.

    British journal of haematology·1993
    Same author

    IgM anti-D as auto-antibody in a case of 'cold' auto-immune haemolytic anaemia.

    Vox sanguinis·1988
    Same author

    Development of multiple antibodies in an apparently 'protected' Rh D negative mother.

    Vox sanguinis·1982
    Same author

    Transfusion of patients with leucocyte antibodies using cotton wool filtered blood.

    Journal of clinical pathology·1981
    Same author

    Four further examples of anti-Inb detected during pregnancy.

    Clinical and laboratory haematology·1981
    Same author

    Changes in the inhibition of specific agglutination by plasma due to microvesicles released from human red cells during storage for transfusion.

    Vox sanguinis·1979

    Area of Science:

    • Immunology
    • Oncology
    • Transfusion Medicine

    Background:

    • Ascitic fluid can harbor unique immunological profiles.
    • Antibody presence in effusions is clinically significant for patient management.

    Purpose of the Study:

    • To document the presence and persistence of anti-Kell (K1) antibodies in ascitic fluid.
    • To compare the antibody profile in ascitic fluid with that in patient serum.

    Main Methods:

    • Case study of a patient with adenocarcinoma.
    • Analysis of antibodies in ascitic fluid and serum.
    • Longitudinal observation of antibody presence.

    Main Results:

    • Anti-Kell (K1) antibodies were detected in the patient's ascitic fluid.
    • These anti-Kell (K1) antibodies persisted for over three years.
    • Anti-A and anti-B antibodies were also found in the ascitic fluid and compared to serum antibodies.

    Conclusions:

    • The ascitic fluid demonstrated a unique antibody profile, including persistent anti-Kell (K1).
    • This finding highlights the importance of analyzing antibodies in effusions for comprehensive patient care.
    • Further research may explore the implications of such localized antibody production in cancer patients.

    Related Experiment Videos